Eli Lilly (NYSE:LLY) had its price target raised by Bank of America/Merrill Lynch (NYSE:BAC) as the company should benefit from the sale of its Sola drug to treat Alzheimer's. A $57 price target was issued with a buy rating.
Shares are higher by about eight tenths of a percent.
Universal Health (NYSE:UHS) had its numbers increased by Credit Suisse (NYSE:CS) as the deal with Ascend should benefit earnings. A $53 price target was set with an outperform rating.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.